Expression of sortilin in pancreatic carcinoma and influence of pancreatic cancer cells by sortilin siRNA knockdown

Abstract

Author(s): Di Xu*, Fan Yu, Shangqing Liu and Rong Cai

Background: Currently, there are few effective therapeutic options for pancreatic cancer patients.Sortilin is a member of vps10p receptor family?reported in many types of cancers.However, the underlying mechanism and prognostic value of sortilin in pancreatic cancer are still unclear. Objective:Understand the expression of sortilin in pancreatic cancer, and analyze its mechanism that affects the occurrence and development of pancreatic cancer.

Share this article

Awards Nomination oncologyradiotherapy scopus oncologyradiotherapy pubmed

Editors List

  • RAOUi Yasser

    Senior Medical Physicist

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh

     

     

     

  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis

     

  • Fava Maria Giovanna

Google Scholar citation report
Citations : 558

Onkologia i Radioterapia received 558 citations as per Google Scholar report

Onkologia i Radioterapia peer review process verified at publons

Indexed In

  • Directory of Open Access Journals
  • Scimago
  • SCOPUS
  • EBSCO A-Z
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20